Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.420
+0.010 (0.71%)
At close: May 5, 2025, 4:00 PM
1.410
-0.010 (-0.70%)
Pre-market: May 6, 2025, 4:49 AM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $44.52 million as of May 6, 2025. Its market cap has decreased by -86.05% in one year.
Market Cap
44.52M
Enterprise Value
-131.32M
1-Year Change
-86.05%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $44.52M, a decrease of -81.07%. That is a compound annual growth rate of -49.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 44.21M | -76.42% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |